BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 103 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $323,896 | -57.0% | 128,022 | +13.2% | 0.00% | – |
Q2 2023 | $753,386 | -47.7% | 113,121 | +46.7% | 0.00% | – |
Q1 2023 | $1,439,283 | -6.9% | 77,132 | +7.2% | 0.00% | – |
Q4 2022 | $1,545,465 | +100.4% | 71,949 | +10.3% | 0.00% | – |
Q3 2022 | $771,000 | -3.9% | 65,219 | +7.3% | 0.00% | – |
Q2 2022 | $802,000 | -34.3% | 60,809 | +4.1% | 0.00% | – |
Q1 2022 | $1,220,000 | +5.7% | 58,386 | +2.9% | 0.00% | – |
Q4 2021 | $1,154,000 | -29.8% | 56,749 | +4.8% | 0.00% | – |
Q3 2021 | $1,645,000 | +14.0% | 54,171 | +9.1% | 0.00% | – |
Q2 2021 | $1,443,000 | -44.7% | 49,669 | -17.9% | 0.00% | -100.0% |
Q1 2021 | $2,609,000 | -8.6% | 60,484 | -2.2% | 0.00% | 0.0% |
Q4 2020 | $2,856,000 | +18.5% | 61,820 | +11.2% | 0.00% | 0.0% |
Q3 2020 | $2,410,000 | -13.3% | 55,597 | +6.0% | 0.00% | 0.0% |
Q2 2020 | $2,780,000 | +149.3% | 52,453 | +5.2% | 0.00% | – |
Q1 2020 | $1,115,000 | +292.6% | 49,854 | +156.7% | 0.00% | – |
Q4 2019 | $284,000 | +107.3% | 19,423 | 0.0% | 0.00% | – |
Q3 2019 | $137,000 | -30.8% | 19,423 | +7.4% | 0.00% | – |
Q2 2019 | $198,000 | – | 18,083 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |